Skip to main content
. 2022 May 4;10:899760. doi: 10.3389/fbioe.2022.899760

FIGURE 4.

FIGURE 4

Injectable thermosensitive hydrogel system for the delivery of VCM in the treatment of osteomyelitis (Tao et al., 2020b). (A) Schematic diagram of the synthesis of antibacterial and osteogenic hydrogels. (B) (a), (b) VCM, VCM-NPs, and VCM-NPs/Gel against S. aureus with different concentrations of VCM; (c) Agar plate diffusion of different groups at 1 and 15 days. (C) (a) The results of μ-CT bone morphology after treatment with VCM/Gel, VCM-NPs/Gel, and vancomycin-calcium sulfate (VCS); (b), (c) Quantitative analysis of μ-CT in each group. (D) (a) Histopathology and IL6 immunohistochemical analysis of the rabbit tibia; (b), (c) Quantitative analysis of new bone formation and (d) Quantitative analysis of IL-6 immunohistochemical staining. (*p < 0.05; **p < 0.01, and ***p < 0.001). BMD, bone mineral density; BV/TV, bone volume/total volume; IL6, interleukin 6; μ-CT, micro-computed tomography; N. Ob/T. Ar, osteoblast number/trabecular bone area; N. OB/B. pm, osteoblast number/bone perimeter; NPs, nanoparticles; S. aureus, Staphylococcus aureus; VCM, vancomycin; ZOI, zone of inhibition.